Equity markets ended the session in mixed fashion, with declining bond yields offering some relief while a significant selloff in semiconductor stocks weighed heavily on major indices. The technology sector bore the
The U.S. Department of State’s August 2026 Visa Bulletin shows forward movement in most categories under the Final Action Dates chart compared to July 2026. U.S. Citizenship and Immigration Services has confirmed
MoreBYD Co., headquartered in Shenzhen, China, holds the title of the world’s largest manufacturer of electric automobiles by volume. The company’s dominance in the electric vehicle sector is significant, reflecting years of
MoreServiceNow (NOW) continues to trade at a premium valuation even after its share price tumbled by roughly 50% from its peak levels. The enterprise software giant, which provides cloud-based workflow automation platforms
MoreThe FTSE 100 closed in positive territory as a combination of easing inflation and rising oil prices lifted sentiment across London’s primary stock index. Investors responded with cautious optimism to fresh inflation
MoreARS Pharmaceuticals (Nasdaq: SPRY) has announced a new collaboration with former NFL quarterback and 2026 Hall of Fame inductee Drew Brees to raise awareness about severe allergic reactions. The campaign centres on
MoreManufacturers seeking to bring novel catalysts to market in the United States face a regulatory landscape that is considerably more demanding than their counterparts in Europe or Canada. Under the Toxic Substances
MoreLast July, investing £20,000 into the FTSE 100 would have been a straightforward, if unremarkable, decision that has since paid off handsomely. The UK blue-chip index climbed 19.1% over the past 12
MoreGlobal oil markets are under intense scrutiny as crude prices push closer to the $100 per barrel threshold, a level not seen in recent trading cycles. The psychological significance of $100 oil
MoreNearly one million people are being pulled into higher tax bands as the government’s freeze on thresholds continues to take effect, new analysis shows. Research by the Taxpayers’ Alliance has found that
MoreHealthcare’s long-promised overhaul of prior authorisation remains a work in progress, with frontline physicians reporting limited improvements despite industry pledges and new federal requirements. A new American Medical Association survey found that
More
